⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27476470 | 0.79 | — | — | |
| SCHEMBL11395193 | 0.76 | LMNA (0.35) | — | |
| SCHEMBL9971665 | 0.74 | — | — | |
| SCHEMBL10336708 | 0.74 | — | — | |
| SCHEMBL1728025 | 0.74 | — | — | |
| SCHEMBL6647527 | 0.72 | — | — | |
| Butane SCHEMBL27550372 | 0.72 | TP53 (0.35) | — | |
| SCHEMBL27590436 | 0.72 | — | — | |
| SCHEMBL11223611 | 0.72 | — | — | |
| SCHEMBL11217878 | 0.72 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1833821-A2 | SULFAMIDES AS ENDOTHELIN RECEPTOR ANTAGONISTS FOR THE TREATMENT OF CARDIOVASCULAR DISEASES | Actelion Pharmaceuticals Ltd. (CH) | 2007-09-19 | — | — | EP | disclosed |
| WO-2006051502-A2 | SULFAMIDES AS ENDOTHELIN RECEPTOR ANTAGONISTS FOR THE TREATMENT OF CARDIOVASCULAR DISEASES | ACTELION PHARMACEUTICALS LTD (CH) | 2006-05-18 | — | — | WO | disclosed |